Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Elevance Health Inc.

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release third quarter 2025 financial results on October 21, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 800-.

Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2025 Results on October 21

Elevance Health is significantly undervalued, trading at a 41% discount to industry peers, despite strong revenue growth and a 2.11% dividend yield. ELV's recent selloff was triggered by bottom-line contraction and lowered FY2025 EPS guidance, but revenue growth remains robust, especially in its Carelon segment. Despite margin pressures from rising Medicaid and ACA costs, ELV maintains strong profitability, low leverage, and shareholder-friendly capital allocation, supporting a defensive investment thesis.

Elevance Health: Undervalued Defensive Giant With Long-Term Upside

INDIANAPOLIS--(BUSINESS WIRE)--Indianapolis Public Schools' Northwest Middle School today celebrated the unveiling of its newly transformed weight room, a project made possible through a partnership with Elevance Health and the Impact Fitness Foundation (IFF). The initiative is part of Elevance Health's ongoing commitment to the whole health of communities and is the fourth fitness space upgrade made in an Indianapolis school, in celebration of the Elevance Health Women's Fort Myers Tipoff, a p.

Northwest Middle School Unveils New Weight Room in Partnership with Elevance Health and Impact Fitness Foundation

ELV exits Part D and trims Medicare Advantage markets, betting on stronger-margin plans to protect profitability.

Elevance Health Shrinks to Grow Stronger: From Part D to Plan B?

REFI, ELV and TAP have been added to the Zacks Rank #5 (Strong Sell) List on September 11, 2025.

New Strong Sell Stocks for September 11th

Bragar Eagel & Squire, P.C. Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Elevance (ELV) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in  Elevance between April 18, 2024, and October 16, 2024 and would like to discuss your legal rights, call Bragar Eagel & Squire partner  Brandon Walker or Marion Passmore directly at (212) 355-4648.

ELEVANCE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Elevance Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

ELV stands out as an outperformer due to strong historical performance, capital returns, and a robust balance sheet. Sector tailwinds and AI-driven efficiency gains present attractive long-term opportunities, while ELV trades at a comparatively low valuation. Key risks include unpredictable medical costs that could continue outpacing premium revenue growth, potentially offsetting AI benefits, though a large loss appears unlikely when investing today.

Elevance Health: Keep It Simple And Buy This Great Business At A Low Valuation

Barclays raised the firm's price target on Elevance Health to $373 from $327 and keeps an Overweight rating on the shares. The firm adjusted estimates and targets in the managed care and healthcare facility group following a "volatile" Q2 earnings season. Group valuations have increased recently, which may be a sign that investor sentiment and estimates have bottomed out, the analyst tells investors in a research note. From here, Barclays sees a number of potential catalysts including September budget deals, final pricing for Medicare Advantage and Affordable Care Act plans and Medicare Advantage star ratings for the 2027 plans. Relative to estimates, the firm believes UnitedHealth (UNH) and CVS Health (CVS) offer the most near-term upside while Molina Healthcare (MOH) has the most downside risk. 11 Sep

Elevance Health price target raised to $373 from $327 at Barclays

INDIANAPOLIS--(BUSINESS WIRE)--The Elevance Health Foundation has awarded 29 new grants totaling more than $6.5 million to support maternal and infant health programs across the country. The funding will drive innovative, scalable solutions spanning pre-conception care, pregnancy, delivery, postpartum, and infant health, with a focus on reducing disparities and improving outcomes. This latest round of funding is part of the Foundation's five-year, $150 million commitment to addressing the physi.

Elevance Health Foundation Awards $6.5 Million to Strengthen Maternal and Infant Health Across the United States

My Top 15 high-growth dividend stocks for September 2025 are collectively 32% undervalued and offer a 1.43% yield with 21.57% five-year dividend growth. The strategy's five-year annualized return is 11.22%, just shy of my 12% target, but it continues to outperform VIG and SPY year-to-date. Rotation in the list brings in DICK'S Sporting Goods, Elevance Health, Intuit, and Marsh & McLennan, replacing stocks that fell below the 12% expected return threshold.

Top 15 High-Growth Dividend Stocks For September 2025

Elevance Health expands beyond insurance into primary care, digital health and pharmacy services, aiming to reshape healthcare delivery.

Is ELV's Push Beyond Insurance a Blueprint for the Healthcare Future?

CVS Health advances with Aetna margin recovery, digital investments and cost savings, making it the stronger healthcare bet over Elevance.

CVS vs. ELV: Which Healthcare Titan Is the Stronger Investment Today?

ELV's focus on value-based care, Carelon integration and CareBridge acquisition drives membership and revenue growth.

Can Elevance Health's Value-Based Care Strategy Fuel Long-Term Growth?

Elevance and peers face earnings pressure from rising medical costs, driven by deferred care, expensive drugs, and persistent medical inflation. The segment has re-rated, and now offers good value. Investor sentiment has returned, and capital is rotating into healthcare.

Elevance Health - Piggy Bank Or Headache?

UnitedHealth and Elevance battle rising costs, but scale, Optum, and Buffett's backing give UNH the edge in restoring investor trust.

UNH or ELV: Which Healthcare Titan Will Regain Investor Trust First?

Federal judge dismisses ELV's lawsuit challenging Medicare Advantage star ratings, leading to a $375M bonus loss tied to its star score.

Elevance Shoots for the Stars But Lands at 3.5: $375M Bonus Gone?

A federal judge in Texas on Tuesday rejected Elevance Health's challenge of the U.S. government's calculation for the health insurer's star ratings for some of its government-backed Medicare plans after the company said improper rounding cost it at least $375 million.

Elevance Health loses bid to challenge US Medicare star ratings

ELV partners with NACHC to bring Food as Medicine into primary care, targeting nutritional insecurities and chronic disease.

Food as Medicine: Elevance Health & NACHC Integrate Nutrition in Care

INDIANAPOLIS--(BUSINESS WIRE)-- #ElevanceHealth--Elevance Health and the National Association of Community Health Centers (NACHC) are proud to announce the integration of Food as Medicine (FAM) programming with primary care Community Health Centers (CHCs). This milestone - built on a shared commitment to whole health and community-centered innovation - marks a transformative step forward in addressing food/nutrition insecurity and diet-related chronic conditions through clinical integration. A Whole Health Appro.

Elevance Health and National Association of Community Health Centers Partnership Integrates Food as Medicine With Primary Care

ELV trims 2025 outlook as medical costs climb, but commercial growth and Carelon's momentum aim to steady performance.

When 90% Isn't an A+: Elevance's Cost Crunch and Carelon's Cushion

Real-time stock quote and overview for ELV